Clinical Trial Update: Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer

View source ↗

Summary

A clinical trial update describes a correlation study evaluating serum HER2 as a biomarker for efficacy of a HER2-targeted antibody-drug conjugate in HER2-low e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HER2-ADC

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: HER 2 Low-expressing Breast Cancer | Status: NOT_YET_RECRUITING